Alexander O. Schuth, COFO and Secretary at Denali Therapeutics Inc. (DNLI), sold 16,706 shares at $23.54 ($401K) on 2024-08-20, disclosed to the SEC on 2024-08-22.
Scheduled sale ($401k) by COFO and Secretary under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $23.54 | 3,353 | $79K | 19.7% |
| 2 | $23.54 | 3,353 | $79K | 19.7% |
| 3 | $23.79 | 2,453 | $58K | 14.6% |
| 4 | $23.79 | 2,453 | $58K | 14.6% |
| 5 | $24.78 | 2,547 | $63K | 15.7% |
| 6 | $24.78 | 2,547 |
| $63K |
| 15.7% |
| Total | $23.99 avg | 16,706 | $401K | 100% |
| Filing → |
| DNLI | SELL | 2026-01-08 | $284K | — | Filing → |
| DNLI | SELL | 2025-08-14 | $40K | — | Filing → |
| DNLI | SELL | 2025-01-08 | $617K | — | Filing → |